O. Lortholary, J. -P. Gangneux, K. Sitbon, B. Lebeau, F

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome J. Guinea, M. Torres-Narbona, P.

Y. Hicheri, G. Cook, C. Cordonnier Clinical Microbiology and Infection

Prevention of toxoplasmosis in transplant patients

Gut bacterial microbiota and obesity

T. Schneider, J. Halter, D. Heim, J. Passweg, M. Stern, A. Tichelli, M

Approach to diagnosis of infective endocarditis

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Candida glabrata fungaemia in intensive care units

J.-P. Van geertruyden Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

Y. Hicheri, G. Cook, C. Cordonnier Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Epidemiology of invasive fungal infections due to Aspergillus spp

Escherichia coli native valve endocarditis

Results from a mathematical model for human monocytic ehrlichiosis

Vector control: a cornerstone in the malaria elimination campaign

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

C. Girmenia, P. Guerrisi, A. M. Frustaci, A. Fama, E. Finolezzi, S

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Training for the infectious diseases speciality in Norway

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar

Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study M.R. Berndsen,

Metagenomics and probiotics

U. Sagel, R.T. Mikolajczyk, A. Krämer

Laboratory diagnosis of Clostridium difficile disease

T.M. File Clinical Microbiology and Infection

Long-term mortality following bloodstream infection

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Current experience in treating invasive zygomycosis with posaconazole

Antimicrobial drug development – the past, the present, and the future

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

W. Eugene Sanders, Christine C. Sanders

Tuberculosis in HIV-infected patients: a comprehensive review

Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? G.N. Pongas, R.E.

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Update on invasive aspergillosis: clinical and diagnostic aspects

J.L. Balcázar Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Community-acquired acute bacterial meningitis in the elderly in Turkey

L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, Y

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005– 2007) O. Lortholary, J.-P. Gangneux, K. Sitbon, B. Lebeau, F. de Monbrison, Y. Le Strat, B. Coignard, F. Dromer, S. Bretagne Clinical Microbiology and Infection Volume 17, Issue 12, Pages 1882-1889 (December 2011) DOI: 10.1111/j.1469-0691.2011.03548.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Overall survival at 3 months after diagnosis of invasive aspergillosis. (a) Patients diagnosed either with one (plain line) or with at least two mycological (dashed line) criteria. (b) Patients given any antifungal regimens containing voriconazole, either alone (plain line) or in combination (dotted line), or any antifungal regimens without voriconazole (dashed line). Clinical Microbiology and Infection 2011 17, 1882-1889DOI: (10.1111/j.1469-0691.2011.03548.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions